Aperam S.A. (LON:0OLF)
32.52
-0.44 (-1.33%)
At close: Dec 4, 2025
Aperam Revenue
Aperam had revenue of 1.41B EUR in the quarter ending September 30, 2025, a decrease of -5.56%. This brings the company's revenue in the last twelve months to 6.19B, down -2.24% year-over-year. In the year 2024, Aperam had annual revenue of 6.26B, down -5.11%.
Revenue (ttm)
6.19B EUR
Revenue Growth
-2.24%
P/S Ratio
0.38
Revenue / Employee
515.78K EUR
Employees
12,007
Market Cap
2.08B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.26B | -337.00M | -5.11% |
| Dec 31, 2023 | 6.59B | -1.56B | -19.18% |
| Dec 31, 2022 | 8.16B | 3.05B | 59.86% |
| Dec 31, 2021 | 5.10B | 1.48B | 40.78% |
| Dec 31, 2020 | 3.62B | -616.00M | -14.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |